Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Understanding the impact of undiagnosed celiac disease and the potential benefits of diagnosis
To understanding the impact of undiagnosed celiac disease and the potential benefits, detection and treatment may have a substantial impact on the health of these subjects and the large numbers of Americans with undiagnosed celiac disease. The outcome measures we will be looking at are Quality of Life, GI Symptoms including diarrhea, constipation, abdominal pain, Tissue Transglutaminase level improvement after 12 weeks on a gluten free diet, bone density, understanding of a gluten free diet.
Joseph Murray, MD
United States: Institutional Review Board
|Mayo Clinic in Rochester||Rochester, Minnesota 55905|